BR112014009887A2 - vacinmas e métodos para desenvolvimento de vacina para indução de imunidade a todos os sorotipos de virus da dengue - Google Patents
vacinmas e métodos para desenvolvimento de vacina para indução de imunidade a todos os sorotipos de virus da dengueInfo
- Publication number
- BR112014009887A2 BR112014009887A2 BR112014009887A BR112014009887A BR112014009887A2 BR 112014009887 A2 BR112014009887 A2 BR 112014009887A2 BR 112014009887 A BR112014009887 A BR 112014009887A BR 112014009887 A BR112014009887 A BR 112014009887A BR 112014009887 A2 BR112014009887 A2 BR 112014009887A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaccines
- methods
- dengue virus
- vaccine development
- virus serotypes
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 2
- 241000725619 Dengue virus Species 0.000 title 1
- 230000036039 immunity Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550982P | 2011-10-25 | 2011-10-25 | |
| PCT/US2012/061893 WO2013063248A1 (en) | 2011-10-25 | 2012-10-25 | Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014009887A2 true BR112014009887A2 (pt) | 2017-04-25 |
Family
ID=48168485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014009887A BR112014009887A2 (pt) | 2011-10-25 | 2012-10-25 | vacinmas e métodos para desenvolvimento de vacina para indução de imunidade a todos os sorotipos de virus da dengue |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150265694A1 (https=) |
| EP (1) | EP2771366A4 (https=) |
| CN (1) | CN104736568A (https=) |
| BR (1) | BR112014009887A2 (https=) |
| CR (1) | CR20140189S (https=) |
| HK (2) | HK1198770A1 (https=) |
| IN (1) | IN2014CN03925A (https=) |
| PH (1) | PH12014500911A1 (https=) |
| SG (1) | SG11201401733VA (https=) |
| WO (1) | WO2013063248A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102181258B1 (ko) | 2012-02-16 | 2020-11-20 | 브이엘피 테라퓨틱스 엘엘씨 | 바이러스 유사 입자 조성물 |
| TWI676636B (zh) | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| US9969986B2 (en) | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| KR102532832B1 (ko) * | 2014-09-11 | 2023-05-16 | 브이엘피 테라퓨틱스 인코포레이티드 | 플라비바이러스 바이러스 유사 입자 |
| JP2019511533A (ja) * | 2016-04-13 | 2019-04-25 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 小児及び若年成人のデングウイルスに対するワクチンの組成物及び方法 |
| CN105732777B (zh) * | 2016-05-05 | 2019-06-04 | 中国人民解放军军事医学科学院微生物流行病研究所 | 黄热病毒特异性检测抗原及其应用 |
| EP3621645A4 (en) | 2017-05-10 | 2021-01-27 | University of Massachusetts | BIVALENT VACCINES AGAINST DENGUE / HEPATITIS B |
| SG11202005792RA (en) | 2017-12-20 | 2020-07-29 | Vlp Therapeutics Llc | Alphavirus replicon particle |
| CN113429479B (zh) * | 2018-04-04 | 2023-03-10 | 中国科学院微生物研究所 | 一种高灵敏度的黄热病毒人源单克隆抗体及其应用 |
| CN109627294B (zh) * | 2018-12-29 | 2020-10-09 | 四川大学 | 一种正确折叠的重组狂犬病毒g蛋白胞外段及其潜在应用 |
| TWI891771B (zh) | 2020-04-17 | 2025-08-01 | 美商Ｖｌｐ醫療股份有限公司 | 冠狀病毒疫苗 |
| AU2021264216A1 (en) | 2020-04-30 | 2022-11-10 | Vlp Therapeutics, Inc. | Cytokine immunotherapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
| CN1551782A (zh) * | 2001-06-01 | 2004-12-01 | ��������ķ������ | 嵌合黄病毒载体 |
| ZA200802176B (en) * | 2005-08-10 | 2009-08-26 | Acambis Inc | Vaccination against dengue virus infection |
-
2012
- 2012-10-25 SG SG11201401733VA patent/SG11201401733VA/en unknown
- 2012-10-25 IN IN3925CHN2014 patent/IN2014CN03925A/en unknown
- 2012-10-25 CN CN201280052904.8A patent/CN104736568A/zh active Pending
- 2012-10-25 HK HK14112282.6A patent/HK1198770A1/xx unknown
- 2012-10-25 HK HK15106951.7A patent/HK1206366A1/xx unknown
- 2012-10-25 BR BR112014009887A patent/BR112014009887A2/pt not_active IP Right Cessation
- 2012-10-25 WO PCT/US2012/061893 patent/WO2013063248A1/en not_active Ceased
- 2012-10-25 PH PH1/2014/500911A patent/PH12014500911A1/en unknown
- 2012-10-25 US US13/660,653 patent/US20150265694A1/en not_active Abandoned
- 2012-10-25 EP EP12842872.9A patent/EP2771366A4/en not_active Withdrawn
-
2014
- 2014-04-25 CR CR20140189F patent/CR20140189S/es unknown
-
2017
- 2017-01-23 US US15/413,347 patent/US10124053B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2771366A4 (en) | 2015-06-03 |
| PH12014500911A1 (en) | 2014-06-09 |
| CN104736568A (zh) | 2015-06-24 |
| SG11201401733VA (en) | 2014-09-26 |
| US10124053B2 (en) | 2018-11-13 |
| US20170202945A1 (en) | 2017-07-20 |
| CR20140189S (es) | 2014-09-24 |
| US20150265694A1 (en) | 2015-09-24 |
| IN2014CN03925A (https=) | 2015-07-03 |
| EP2771366A1 (en) | 2014-09-03 |
| HK1206366A1 (en) | 2016-01-08 |
| WO2013063248A1 (en) | 2013-05-02 |
| HK1198770A1 (en) | 2015-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014009887A2 (pt) | vacinmas e métodos para desenvolvimento de vacina para indução de imunidade a todos os sorotipos de virus da dengue | |
| IL262123A (en) | Influenza virus vaccines and uses thereof | |
| IL232780A0 (en) | Influenza virus vaccines and uses thereof | |
| IL261204A (en) | Influenza virus vaccines and their use | |
| CO6811814A2 (es) | Vacuna de virus dengue inactivado | |
| PL3418300T3 (pl) | Neutralizujące przeciwciała przeciwko wirusowi grypy A i ich zastosowania | |
| EP2753345A4 (en) | POLYPEPTIDIMPFSTOFF | |
| IL240488A0 (en) | Immunogenic composition for mers coronavirus infection | |
| EP2575876A4 (en) | Multivalent synthetic nanocarrier vaccines | |
| BR112013032675A2 (pt) | composição adjuvante de vacina compreendendo partículas de inulina | |
| BR112014010658A2 (pt) | antígenos e vacinas direcionadas contra enterovírus humano | |
| CO6801675A2 (es) | Dispositivo y cápsula para preparar una bebida | |
| EP2595653A4 (en) | INFLUENZA VACCINE | |
| HUE043091T2 (hu) | Immunogén készítmény | |
| EP2876161A4 (en) | VACCINE | |
| CO6870003A2 (es) | Vacunas bovinas y métodos | |
| HUE044772T2 (hu) | Immunogén készítmény | |
| DK2935313T3 (da) | Vacciner mod hepatitis B-virus | |
| EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
| EP2640417A4 (en) | MULTIVALENCE VACCINE AGAINST FILARIOSIS | |
| BR112014005756A2 (pt) | vacina | |
| BR112013031760A2 (pt) | vacina contra coronavírus canino | |
| EP2931304A4 (en) | WT1 VACCINE | |
| IL235101A0 (en) | Multivalent breast cancer vaccine | |
| EP2969005A4 (en) | WAXED INFLUENZA VIRUSES AND VACCINES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2485 DE 21-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |